Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Hertz, D. Taylor, E.P. Trulock, M.M. Boucek, P. Mohacsi, L. Edwards, et al.
The Registry of International Society for Heart and Lung Transplantation: nineteenth official report: 2002.
J Heart Lung Transplant, 21 (2002), pp. 950-970
[2.]
E.P. Trulock.
Lung transplantation.
Am J Resp Crit Care Med, 155 (1997), pp. 789-818
[3.]
J.D. Christie, J.E. Bavaria, H.I. Palevsky, L. Litzky, N.P. Blumenthal, L.R. Kaiser, et al.
Primary graft failure following lung transplantation.
Chest, 114 (1998), pp. 51-60
[4.]
R. Anglés, L. Tenorio, C. Bravo, J. Teixidor, M. Rochera, F.J. De Latorre, et al.
Lesión de reimplantación en el postoperatorio del trasplante pulmonar. Incidencia, factores predictivos, pronósticos y evolución.
Med Clin (Barc), 113 (1999), pp. 81-84
[5.]
R.C. King, R.A. Oliver, A.R. Bins, F. Rodríguez, R.C. Kanithanon, T.M. Daniel, et al.
Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation.
Ann Thorac Surg, 69 (2000), pp. 1681-1685
[6.]
G. Thabut, I. Vinatier, J.B. Stern, G. Leseche, P. Loirat, M. Fournier, et al.
Primary graft failure following lung transplantation: predictive factors of mortality.
Chest, 121 (2002), pp. 1876-1882
[7.]
J. Padilla, V. Calvo, J. Pastor, E. Blasco, F. París.
Trasplante unipulmonar y fracaso primario del injerto.
Arch Bronconeumol, 38 (2002), pp. 16-20
[8.]
A.K. Qayumy, M. Nikbakhat-Sangari, D.V. Godin.
The relationship of ischemia-reperfusion injury of transplanted lung and up-regulation of major histocompatibility complex II on host peripheral lymphocytes.
J Thorac Cardiovasc Surg, 115 (1998), pp. 978-989
[9.]
S.M. Fiser, C.G. Tribble, S.M. Long, A.K. Kaza, J.E. Kern, D.R. Jones, et al.
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
Ann Thorac Surg, 73 (2002), pp. 1041-1048
[10.]
J. Padilla, V. Calvo, J. Teixidor, A. Varela, M. Carbajo, A. Álvarez.
Pulmonary “twinning” transplantation precedure.
Transplant Proc, 34 (2002), pp. 1287-1289
[11.]
A.J. Fisher, S.C. Donnelly, N. Hirani, C. Haslett, R.M. Strieter, J.H. Dark, et al.
Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.
Am J Respir Crit Care Med, 163 (2001), pp. 259-265
[12.]
A.M. Ciccone, B.F. Meyers, T.J. Guthrie, R.J. Battafarano, E.P. Trulock, J.D. Cooper, et al.
Does donor cause of death affect the outcome of lung transplantation?.
J Thorac Cardiovasc Surg, 123 (2002), pp. 429-436
[13.]
L.L. Schulman, T. Anandarangam, D.W. Leibowitz, M.R. Ditullio, C.C. McGregor, M.E. Galantowicz, et al.
Four year prospective study of pulmonar venous thrombosis after lung transplantation.
J Am Soc Echocardiogr, 14 (2001), pp. 806-812
[14.]
M.A. Gillette, D.R. Hess.
Ventilator-induced lung injury and the evolution of lung-protective strategies in acute respiratory distress syndrome.
Respir Care, 46 (2001), pp. 130-148
[15.]
R.F. Kelly.
Current strategies in lung preservation.
J Lab Clin Med, 136 (2000), pp. 427-440
[16.]
M. De Perrot, S. Keshavjee.
Lung preservation.
Curr Opin Organ Transplant, 6 (2001), pp. 223-230
[17.]
M.H. Yacoub, A. Khaghani, N. Banner, S. Tajkarimi, M. Fitzgerald.
Distant organ procurement for heart and lung transplantation.
Transplant Proc, 21 (1989), pp. 2548-2550
[18.]
D.L. Nelson, M.M. Cox.
Lehninger.
Principles of bioichemistry, pp. 448-449
[19.]
D.N. Hopkinson, M.S. Bhabra, T.L. Hooper.
Pulmonary graft preservation: a worldwide survey of current clinical practice.
J Heart Lung Transplant, 17 (1998), pp. 525-531
[20.]
P.A. Clavien, P.R. Harvey, S.M. Strasberg.
Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies.
Transplantation, 53 (1992), pp. 957-978
[21.]
R.L. Hardesty, R. Aeba, J.M. Armitage, R.L. Kormos, B.P. Griffith.
A clinical trial of University of Wisconsin solution for pulmonary preservation.
J Thorac Cardiovasc Surg, 105 (1993), pp. 660-666
[22.]
M. Rinaldi, L. Martinelli, G. Volpato, G. Minzioni, C. Goggi, V. Mantovani, et al.
University of Wisconsin solution provides better lung preservation in human lung transplantation.
Transplant Proc, 27 (1995), pp. 2869-2871
[23.]
C. Müller, H. Furst, H. Reichenspurner, J. Briegel, J. Groh, B. Reichart.
Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group.
Transplantation, 68 (1999), pp. 1139-1143
[24.]
M. Strüber, M. Wilhelmi, W. Harringer, J. Niedermeyer, M. Anssar, A. Künseberck, et al.
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation.
Eur J Cardiothorac Surg, 19 (2001), pp. 190-194
[25.]
S. Fischer, A. Matte-Martyn, M. De Perrot, T. Waddell, Y. Sekine, M. Hutcheon, et al.
Low-potassium dextran preservation solution improves lung function after human lung transplantation.
J Thorac Cardiovasc Surg, 120 (2001), pp. 594-596
[26.]
A. D'Armini, A. Grande, M. Rinaldi, C. Goggi, M. Vigano.
Prospective randomized clinical study of Celsior versus Winsconsin in double lung transplant.
J Heart Lung Transplant, 20 (2000), pp. 183
[27.]
G. Thabut, I. Vinatier, O. Brugière, G. Lesèche, P. Loiret, A. Bisson, et al.
Influence of preservation solution on early graft failure in clinical lung transplantation.
Am J Respir Crit Care Med, 164 (2001), pp. 1204-1208
[28.]
O. Baron, S. Fabre, M. Treilaud, O. Al Habasch, D. Duveau, J.L. Michaud, et al.
Retrospective clinical comparation of Celsior solution to modified blood Wallwork solution in lung transplantation for cystic fibrosis.
Progr Transplant, 12 (2002), pp. 176-180
[29.]
C.R.B. Welbourn, G. Goldman, I.S. Paterson, C.R. Valeri, D. Shepro, H.B. Hechtman.
Pathophysiology of isquemia reperfusion injury: central role of the neutrophil.
Br J Surg, 78 (1991), pp. 651-655
[30.]
A.B. Al-Mehdi, H. Shuman, A.B. Fisher.
Intracellular generation of reactive oxygen species during nonhyposic lung isquemia.
Am J Physiol, 272 (1997), pp. 1294-1300
[31.]
J.R. Vane, E.E. Angaard, R.M. Botting.
Regulatory functions of vascular endothelium.
N Engl J Med, 323 (1990), pp. 27-36
[32.]
K.C. Meyer, R.B. Love, J.J. Zimmerman.
The therapeutic potential of nitric oxide in lung transplantation.
Chest, 113 (1998), pp. 1360-1371
[33.]
B.F. Meyers, J. Lynch, E.P. Trulock, T. Guthrie, J.D. Cooper, C.J. Patterson.
Lung transplantation: a decade of experience.
Ann Surg, 230 (1999), pp. 362-370
[34.]
R.J. Keenan, J.D. Vega.
Lung transplantation for emphisema.
Advanced therapy in thoracic surgery, pp. 347-353
[35.]
S. Fujino, I. Nagahiro, M. Yanashita, M. Yano, R.A. Schmid, J.D. Cooper, et al.
Preharvest nitroprusside flush improve posttransplantation lung function.
J Heart Lung Transplant, 16 (1997), pp. 1073-1080
[36.]
S. Fujino, I. Nagahiro, A.N. Triantafillou, C.H. Boasquevisque, M. Yano, J.D. Cooper, et al.
Inhaled nitric oxide at the time of harvest improves early lung allograft function.
Ann Thorac Surg, 63 (1997), pp. 1383-1390
[37.]
G. Thabut, O. Brugière, G. Leseche, J.B. Stern, D.J. Fradj, P. Herve, et al.
Preventive effect of inhaled nitric oxide and pentoxifylline on isquemia/reperfusion injury after lung tansplantation.
Transplantation, 71 (2001), pp. 1295-1330
[38.]
A. Ardehali, H. Laks, M. Levine, R. Shpiner, D. Ross, L. Watson, et al.
A prospective trial of inhaled nitric oxide in clinical lung transplantation.
Transplantation, 72 (2001), pp. 112-115
[39.]
M. Meade, J. Granton, A. Matte-Martyn, K. McRae, P.M. Gripps, B. Weaver, et al.
A randomized trial of inhaled nitric oxide to prevent reperfusion injury following lung transplantation.
J Heart Lung Transplant, 20 (2001), pp. 254-255
[40.]
Y. Naka, D. Roy, H. Liao, N.C. Chowdhury, R.E. Michler, M.P. Oz, et al.
cAMP-mediated vascular protection in an orthoptic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation.
Circ Res, 79 (1996), pp. 773-783
[41.]
C. Chiang, K. Wu, C. Yu, H. Yan, W. Perng, C. Wu.
Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion injury.
Am J Respir Crit Care Med, 160 (1999), pp. 1319-1323
[42.]
T. Vainikka, L. Heikkila, S. Kukkonen, H. Toivonen, K. Verkkala, S. Mattila.
Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation.
Eur Surg Res, 31 (1999), pp. 429-436
[43.]
S. Sasaki, K. Yasuda, J.D. McCully, J. LoCicero.
Calcium channel blocker enhances lung preservation.
J Heart Lung Transplant, 18 (1999), pp. 127-132
[44.]
T. Wittwer, M. Grote, P. Oppelt, U. Franke, H. Schaefers, T. Wahlers.
Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation.
J Heart Lung Transplant, 20 (2001), pp. 358-363
[45.]
Y. Sato, J.C. Hogg, D. English, S.F. Van Eeden.
Endothelin-1 changes polymorphonuclear leukocytes deformability and CD1 1b expression and promotes their retention in the lung.
Am J Respir Cell Mol Biol, 23 (2000), pp. 404-410
[46.]
H. Mal, M. Dehoux, C. Sleiman, J. Boczkowski, G. Lesèche, R. Pariente, et al.
Early release of proinflammatory citokines after lung transplantation.
Chest, 113 (1998), pp. 645-651
[47.]
M. De Perrot, Y. Sekine, S. Fischer, T.K. Waddell, K. McRae, M. Liu, et al.
Interleukine 8 release during early reperfusion precdicts graft function in human lung transplantation.
Am J Respir Crit Care Med, 165 (2002), pp. 211-215
[48.]
C.A. Janeway, P. Travers.
Inmunobiology: the inmune system in health and disease, pp. 9-14
[49.]
D.M. Follete, S.M. Ruditch, W.D. Babcock.
Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death.
J Heart Lung Transplant, 17 (1998), pp. 423-429
[50.]
J. Padilla Alarcón.
Obtención y preservación del órgano.
El trasplante pulmonar, pp. 45-55
[51.]
M.R. Zamora, R.D. Davis, S.H. Keshavjee, L. Schulman, J. Levin, U. Ryan, et al.
Complement inhibition attenuates human lung transplant reperfusion injury. A multicenter trial.
Chest, 116 (1999), pp. 46S
[52.]
A. Salvatierra, F. Velasco, M. Rodríguez, A. Álvarez, R. López-pedrera, R. Ramírez, et al.
C1-esterasa inhibitor prevents early pulmonary dysfunction after lung transplantation in dog.
Am J Respir Crit Care Med, 155 (1977), pp. 1147-1154
[53.]
A. Salvatierra, R. Guerrero, M. Rodríguez, A. Álvarez, F. Soriano, R. López-pedrera, et al.
Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog.
Circulation, 104 (2001), pp. 2975-2980
[54.]
M. Strüber, C. Hagl, S.W. Hirt, J. Cremer, W. Harringer, A. Haverich.
C1-esterasa inhibitor in graft failure after lung transplantation.
Intensive Care Med, 25 (1999), pp. 1315-1318
[55.]
R.J. Novick, K.E. Gehman, I.S. Ali, J. Lee.
Lung preservation: the importance of endothelial and alveolar type II cell integrity.
Ann Thorac Surg, 62 (1996), pp. 302-314
[56.]
C. Casals, A. Varela, M.L. Ruano, F. Valino, J. Pérez-Gil, N. Torre, et al.
Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation.
Am J Respir Crit Care Med, 157 (1998), pp. 43-49
[57.]
R.J. Novick.
Innovative techniques to enhance lung preservation.
J Thorac Cardiovasc Surg, 123 (2002), pp. 3-5
[58.]
M. Strüber, S.W. Hirt, J. Cremar, W. Harriger, A. Haverich.
Surfactant replacement in reperfusion injury after clinical lung transplantation.
Intensive Care Med, 25 (1999), pp. 862-864
[59.]
C.N. Steimle, T.P. Guyynn, M.L. Morganroth, S.F. Bolling, K. Carr, G.M. Deeb.
Neutrophils are not necessary for isquemia-reperfusion lung injury.
Ann Thorac Surg, 53 (1992), pp. 64-73
[60.]
M.J. Eppinger, M.L. Jones, G.M. Deeb, S.F. Bolling, P.A. Ward.
Pattern of injury and role of neutrophils in reperfusion lung injury.
J Surg Res, 58 (1995), pp. 713-718
[61.]
M.J. Eppinger, G.M. Deeb, S.F. Bolling, P.A. Ward.
Mediators of ischemia- reperfusion injury of rat lung.
Am J Pathol, 150 (1997), pp. 1773-1784
[62.]
N. Richter, G. Raddatz, G. Steinhoff, H.J. Schafers, H.J. Schlitt.
Transmission of donor lymphocytes in clinical lung transplantation.
Transplant Int, 7 (1994), pp. 414-419
[63.]
S.M. Fiser, C.G. Tribble, S.M. Long, A.K. Kaza, J.A. Kern, I.L. Kron.
Pulmonary macrophages are involved in reperfusion injury after lung transplantation.
Ann Thorac Surg, 71 (2002), pp. 1134-1138
[64.]
S. Kokura, R. Wolf, T. Yoshikawa, D.N. Granger, T.Y. Aw.
T-lymphocyte- derived tumor necrosis factor exacerbates anoxia-reoxigenation-induced neutrophil-endotelial cell adhesion.
Circ Res, 86 (2000), pp. 205-213
[65.]
M.A. Hidalgo, P. Saratchandra, P.R. Fryer, B.J. Fuller, C.J. Green.
Effects of hipothermic storage on the vascular endothelium: a scanning electron microscope study of morphological change in human vein.
J Cardiovasc Surg (Torino), 36 (1996), pp. 25-32
[66.]
R.S. Andrade, O.D. Wangensteen, J.K. Jo, M.Y. Tsai, R.M. Bolman.
Effect of hypothermic pulmonary artery flushing on capilary filtration coefficient.
Transplantation, 70 (2000), pp. 267-271
[67.]
K. Kayano, K. Toda, Y. Naka, D.J. Pinsky.
Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model.
Circulation, 100(Suppl 2) (1999), pp. 257-261
[68.]
A. Varela, C.G. Montero, M. Córdoba, A. Antequera, M. Pérez, M.J. Tabuenca, et al.
Improved distribution of pulmonary flush solution to the traqueobronchial wall in pulmonary transplantation.
Eur Surg Res, 29 (1997), pp. 1-4
[69.]
T. Wittwer, A. Fehrenbach, D. Meyer, H. Brandes, J. Albes, J. Richter, et al.
Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation.
J Heart Lung Transplant, 19 (2000), pp. 976-983
[70.]
M. Strüber, J. Hohlfeld, T. Kofidis, G. Warnecke, J. Neidermeyer, S. Sommer, et al.
Surfactant function in lung transplantation after 24 hours isquemia: advantage of retrograde flush perfusion for preservation.
J Thorac Cardiovasc Surg, 123 (2002), pp. 98-103
[71.]
A. Varela, M. Córdoba, S. Serrano-Fiz, R. Burgos, C. Monter, G. Téllez, et al.
Early lung allograft function after retrograde and anterograde preservation.
J Thorac Cardiovasc Surg, 114 (1977), pp. 1119-1120
[72.]
A. Álvarez, A. Salvatierra, R. Lama, J. Algar, S. Cerezo, F. Santos, et al.
Preservation with a retrograde second flushing of Eurocollins in clinical lung transplantation.
Transplant Proc, 31 (1999), pp. 1088-1090
[73.]
F. Venuta, E.A. Rendina, M. Bufi, G.D. Rocca, T. De Giacomo, M.G. Costa, et al.
Preimplantation retrograde pneumoplegia in clinical lung transplantation.
J Thorac Cardiovasc Surg, 118 (1999), pp. 107-114
[74.]
S.D. Lick, P.S. Brown, M. Kurusz, R. Vertrees, C.K. McQuitty, W.E. Johnston.
Technique of controlled reperfusion of the transplanted lung in humans.
Ann Thorac Surg, 69 (2000), pp. 910-912
[75.]
H. Tanaka, Y. Chiba, M. Sasaki, S. Matsukawa, R. Muruoka.
Relationship between flushing pressure and nitric oxide production in preserved lung.
Transplantation, 65 (1998), pp. 460-464
[76.]
M. Haniuda, S. Hasegawa, T. Shiraisi, C.D. Dresler, J.D. Cooper, G.A. Patterson.
Effects of inflation volume during lung preservation on pulmonary capillary permeability.
J Thorac Cardiovasc Surg, 113 (1996), pp. 85-93
[77.]
T. Fukuse, T. Hirata, S. Ishikawa, T. Shoji, T. Yoshimura, Q. Chen, et al.
Optimal alveolar oxygen concentration for cold storage of the lung.
Transplantation, 72 (2001), pp. 300-304
[78.]
T. Fukuse, T. Hirata, T. Nakamura, M. Kawashima, S. Hitomi, H. Wada.
Influence of deflated and anaerobic conditions during cold storage on rat lungs.
Am J Respir Crit Care Med, 160 (1999), pp. 621-627
[79.]
T. Sakuma, C. Tsukano, M. Ishigaki.
Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs.
Transplantation, 69 (2000), pp. 1785-1793
[80.]
J.D. Puskas, T. Hirai, N.A. Christie, E. Mayer, A.S. Slustky, G.A. Patterson.
Reliable 30-hour lung preservation with donor hyperinsuflation.
J Thorac Cardiovasc Surg, 104 (1992), pp. 1075-1083
[81.]
F.L. Grover, D.A. Fullerton, M.R. Zamora, C. Mills, B. Ackerman, D. Badesch, et al.
The past, present, and future of lung transplantation.
Am J Surg, 173 (1997), pp. 523-533
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica
